Revolution Medicines Interview Guide

Revolution Medicines is a pioneering clinical-stage precision oncology company focused on developing groundbreaking targeted therapies for RAS-addicted cancers. With a robust research and development pipeline that includes RAS(ON) Inhibitors designed to suppress various oncogenic variants of RAS proteins and RAS Companion Inhibitors for synergistic treatment strategies, the company is dedicated to improving outcomes for patients affected by cancers with mutations in the RAS signaling pathway. By fostering a collaborative and innovative environment, Revolution Medicines brings together talented professionals who are committed to advancing drug discovery and enhancing patient care, ensuring that they remain at the cutting edge of the biotech and biopharma industries.